Description
Medicover VERAgene NIPT Test
VERAgene NIPT Test and Carrier Screen is the only non-invasive prenatal test (NIPT) that can simultaneously screen for aneuploidies (Down Syndrome, Edward Syndrome, Patau Syndrome) sex chromosome aneuploidy (Turner Syndrome, Kleinfelter Syndrome), microdeletions (22q Deletion or Di George Syndrome) and 100 single gene diseases (Cystic Fibrosis, B-Thalasaemia, Sickle Cell Disease etc) . The diseases screened by VERAgene are associated with a moderate to severe health impact on the health, development and quality of life on the baby. By combining detection of aneuploidies and microdeletions with the screening of monogenic diseases, VERAgene provides a comprehensive solution to prospective parents.
It works for single and twin pregnancies, IVF own egg pregnancies and those with a vanishing twin.
VERAgene needs a maternal blood sample, and a buccal swab sample from the biological father. The maternal blood contains cell-free DNA from both the mother and the fetus. This cell-free DNA is isolated and analyzed along with the father’s DNA sample for any potential genetic mutations using next generation sequencing. Sophisticated bioinformatics algorithms are then used to compute the risk of the fetus having a monogenic disease.
Click here to learn more about Understanding NIPT in Pregnancy
Conditions screened for by Veragene (in pink)
Our fee includes either a complimentary scan in our Cardiff Clinic or a complimentary home or work phlebotomy blood sample anywhere in the UK or Ireland.
